The Health 202: Why the medical community is concerned about a genetic testing boom
By Paige Winfield Cunningham,
Washington Post
| 03. 27. 2018
The Food and Drug Administration’s move to allow 23andMe to screen people for breast cancer risks may unleash a flood of new direct-to-consumer genetic tests.
But some genetic experts and members of the medical community are raising concerns about whether consumers can truly understand the test results — and how they will handle such sensitive information.
Emily Drabant Conley, 23andMe’s vice president of business development, called the FDA’s decision this month to let the private company offer the country’s first and only direct-to-consumer genetic health risk test for cancer an “enormous win.”
The company is hoping to expand its genetic testing offerings to allow people to understand more about how their DNA affects the risk of developing a certain disease.
“We as a company absolutely want to continue expanding. There are still things that are not in the product today where genetics can be quite informative to consumers,” Drabant Conley said. “We are absolutely in the process of working to get more reports cleared through the FDA on a variety of topics we know consumers care about.”
Rep. Thomas Massie (R-Ky.)...
Related Articles
By Laura Hughes, Financial Times | 05.20.2026
Sophie and her husband are set to spend more than £100,000 in travel and medical bills as they fly between England and the US in their bid to have another child.
The couple are undergoing IVF treatment in New York...
By Gina Kolata, The New York Times | 05.25.2026
In a small, preliminary study, an experimental gene-editing treatment dramatically lowered cholesterol levels, perhaps permanently, after just one infusion, scientists reported on Monday.
If confirmed in larger studies, researchers hope the findings may lead to a one-and-done way to prevent...
By Nanette Elster, Kayhan Parsi, and Art Caplan, The American Journal of Bioethics | 05.06.2026
“Better babies.” “Fitter families.” “Survival of the fittest.” “Three generations of imbeciles are enough.” These phrases are not merely historical reminders of the United States’ regrettable eugenic past but are appearing in an increasingly eugenic present. Eugenics may have seemed...
By Rob Stein, NPR [cites CGS' Katie Hasson] | 05.06.2026
Justin Schleede reaches onto a black lab bench to pick up a tray of small plastic tubes.
"These are saliva samples as well as blood," says Schleede, a geneticist who runs Herasight Inc.'s lab in Morrisville, N.C. "We also...
